Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease

被引:0
|
作者
Swaminathan, Aparna C. [1 ,2 ]
McFatrich, Molly [3 ]
Mkumba, Laura [3 ]
Wright, Lauren [3 ]
Redlich, Carrie A. [4 ]
Snyder, Laurie D. [1 ,2 ]
Reeve, Bryce B. [1 ,3 ]
Patel, Divya [5 ]
Gulati, Mridu [4 ]
机构
[1] Duke Clin Res Inst, Durham, NC 27701 USA
[2] Duke Univ, Med Ctr, Durham, NC 27710 USA
[3] Duke Univ, Sch Med, Durham, NC USA
[4] Yale Sch Med, New Haven, CT USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
关键词
Interstitial Lung diseases; Pulmonary fibrosis; AMERICAN THORACIC SOCIETY; HYPERSENSITIVITY PNEUMONITIS; ANTIGEN;
D O I
10.1186/s12931-024-03000-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundIdentification of exposures in patients with interstitial lung diseases (ILDs) is essential for diagnosis and management and can be facilitated through the use of exposure questionnaires. However, for most ILDs, a patient-focused questionnaire is lacking. Cognitive interviewing is a methodology used to evaluate sources of understanding and misunderstanding in a questionnaire and to provide evidence of content validity. We developed and refined a new exposure questionnaire for patients with fibrotic ILDs by using cognitive interviewing to establish its understandability and content validity.MethodsAn exposure assessment questionnaire was developed by a multidisciplinary team. Cognitive interviews with 24 patients with fibrosing ILDs were conducted by trained interviewers over the phone or Zoom using a semi-structured interview guide. The questionnaire was amended based on the interviewers' interpretation of sources of misunderstanding. The revised questionnaire was tested in a second round of cognitive interviews with a different group of 24 patients.ResultsAmong the 48 patients who completed interviews, mean age was 61 years, 58.3% were male and 75.0% were white. Based on the first round of cognitive interviews, the multidisciplinary team modified the questions, organization, and instructions of the questionnaire to facilitate recall, adjust for exposures that were frequently misunderstood or required clarification, and focus on clinically relevant exposures. The revised questionnaire performed well in the second round of interviews.ConclusionAn exposure questionnaire, developed with input from patients, can be used to assess clinically relevant exposures in adults with fibrosing ILDs. This is the first questionnaire for all types of fibrosing ILD to have undergone content validation.
引用
收藏
页数:9
相关论文
共 6 条
  • [1] Environmental and occupational exposures in interstitial lung disease
    Lee, Cathryn T.
    Feary, Johanna
    Johannson, Kerri A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (05) : 414 - 420
  • [2] Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease Evidence Review and Practical Considerations
    Copeland, Carla R.
    Collins, Bridget F.
    Salisbury, Margaret L.
    CHEST, 2021, 160 (01) : 219 - 230
  • [3] Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
    Tao Chen
    Amy Po Yu Tsai
    Seo Am Hur
    Alyson W. Wong
    Mohsen Sadatsafavi
    Jolene H. Fisher
    Kerri A. Johannson
    Deborah Assayag
    Julie Morisset
    Shane Shapera
    Nasreen Khalil
    Charlene D. Fell
    Helene Manganas
    Gerard Cox
    Teresa To
    Andrea S. Gershon
    Nathan Hambly
    Andrew J. Halayko
    Pearce G. Wilcox
    Martin Kolb
    Christopher J. Ryerson
    Respiratory Research, 22
  • [4] Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
    Chen, Tao
    Tsai, Amy Po Yu
    Hur, Seo Am
    Wong, Alyson W.
    Sadatsafavi, Mohsen
    Fisher, Jolene H.
    Johannson, Kerri A.
    Assayag, Deborah
    Morisset, Julie
    Shapera, Shane
    Khalil, Nasreen
    Fell, Charlene D.
    Manganas, Helene
    Cox, Gerard
    To, Teresa
    Gershon, Andrea S.
    Hambly, Nathan
    Halayko, Andrew J.
    Wilcox, Pearce G.
    Kolb, Martin
    Ryerson, Christopher J.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [5] A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease
    Dodia, Neal
    Amariei, Diana
    Kenaa, Blaine
    Corwin, Doug
    Chelala, Lydia
    Britt, E. James
    Sachdeva, Ashutosh
    Luzina, Irina G.
    Hasday, Jeffrey D.
    Shah, Nirav G.
    Atamas, Sergei P.
    Franks, Teri J.
    Burke, Allen P.
    Hines, Stella E.
    Galvin, Jeffrey R.
    Todd, Nevins W.
    RESPIRATORY MEDICINE, 2021, 179
  • [6] Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease
    Banaszak, Lauren G.
    Smith-Simmer, Kelcy
    Shoger, Kyle
    Lovrien, Lauren
    Malik, Amy
    Sandbo, Nathan
    Sultan, Samir
    Guzy, Robert
    Lowery, Erin M.
    Churpek, Jane E.
    RESPIRATORY MEDICINE, 2023, 220